The in vitro effect of kynurenic acid on the rainbow trout (Oncorhynchus mykiss) leukocyte and splenocyte activity

Polish Journal of Veterinary Sciences

Volumn 17, Issue 3, 2014, Pages 453-458

  Malaczewska J ^a   Siwicki, A K ^a   Wojcik R ^a   Turski, W A ^b   Kaczorek, E ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Kynurenic acid; Lymphocyte and phagocyte activity; Rainbow trout

Indexed keywords

ANIMALIA; ONCORHYNCHUS MYKISS;

KYNURENIC ACID;

ANIMAL; ARTICLE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; LEUKOCYTE; LYMPHOCYTE; RAINBOW TROUT; SPLEEN;

ANIMALS; CELL SURVIVAL; KYNURENIC ACID; LEUKOCYTES; LYMPHOCYTES; ONCORHYNCHUS MYKISS; SPLEEN;

EID: 84908502587     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: 10.2478/pjvs-2014-0065     Document Type: Article

References (21)

1. Baran H, Staniek K, Kepplinger B, Gille L, Stolze K, Nohl H (2001) Kynurenic acid influences the respiratory parameters of rat heart mitochondria. Pharmacology 62: 119-123.
2. Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2: 1-19.
3. Chettri JK, Holten-Andersen L, Buchmann K (2010) Factors influencing in vitro respiratory burst assays with head kidney leucocytes from rainbow trout, Oncorhynchus mykiss (Walbaum). J Fish Dis 33: 593-602.
4. Chung S, Secombes SJ (1988) Analysis of events occurring within teleost macrophages during the respiratory burst. Comp Biochem Phys B 89: 539-544.
5. de Souza FR, Fontes FL, da Silva TA, Coutinho LG, Leib SL, Agnez-Lima LF (2011) Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis. BMC Med Genet 12: 51.
6. Di Serio C, Cozzi A, Angeli I, Doria L, Micucci I, Pellerito S, Mirone P, Masotti G, Moroni F, Tarantini F (2005) Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. CellMol Neurobiol 25: 981-993.
7. Fallarini S, Magliulo L, Paoletti T, de Lalla C, Lombardi G (2010) Expression of functional GPR35 in human iNKT cells. Biochem Biophys Res Commun 398: 420-425.
8. Kaszaki J, Palásthy Z, Érczes D, Rácz A, Torday C, Varga G, Vécsei L, Boros M (2008) Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil 20: 53-62.
9. Kudo Y, Boyd CA, Sargent IL, Redman CW (2001) Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J Physiol 535: 207-215.
10. Lugo-Huitrón R, Blanco-Ayala T, Ugalde-Mun? iz P, Carrillo-Mora P, Pedraza-Chaverrt J, Silva-Adaya D, Maldonado PD, Torres I, Pinzón E, Ortiz-Islas E, López T, Garcta E, Pineda B, Torres-Ramos M, Santamaría A, La Cruz VP (2011) On the antioxidant properties of kynurenic acid: free radical scavening activity and inhibition of oxidative stress. Neurotoxicol Teratol 33: 538-547.
11. Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E (2007) The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression-and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett 28: 826-831.
12. Magnadóttir B (2006) Innate immunity of fish (overview). Fish Shellfish Immunol 20: 137-151.
13. Małaczewska J, Siwicki AK, Wójcik RM, Kaczorek E, Turski WA (2014) Effect of oral administration of kynurenic acid on the activity of the peripheral blood leukocytes in mice. Centr Eur J Immunol 39: 6-13.
14. Mándi Y, Vécsei L (2012) The kynurenine system and immunoregulation. J Neural Transm 119: 197-209.
15. Moroni F, Fossati S, Chiarugi A, Cozzi A (2007) Kynurenic acid actions in brain and periphery. Int Congr Ser 1304: 305-313.
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
17. Rook GA, Steele J, Umar S, Dockrell HM (1985) A simple method for the solubilisation of reduced NBT and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods 82: 161-167.
18. Terness P, Bauer TM, Röse L, Dufter C, Watzlik A, Simon H, Opelz G (2002) Inhibition of allogenic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196: 447-457.
19. Tiszlavicz Z, Németh B, Fülöp F, Vécsei L, Tápai K, Ocsovszky I, Mándi Y (2011) Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils. Naunyn Schmiedebergs Arch Pharmacol 383: 447-455.
20. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281: 22021-22028.
21. Wejksza K, Rzeski W, Turski WA (2009) Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells. Pharmacol Rep 61: 751-756.